Led · Equity · Nov 2023

BeMe Health operates a digital behavioral-health platform that delivers mental health interventions specifically for teens and young adults. The platform provides 24/7 accessibility, interactive tools (mood reflection, skill-building activities, and evidence-based assessments), personalized 1:1 coaching and clinical linkage, and 24/7 crisis support. BeMe works with health plans, employers, and community organizations to offer a digital-first approach to interventional teen mental health and is SOC 2 Type 2 compliant. The company announced it closed over $12 million in additional funding to fuel growth ahead of a planned Series A financing round. The new capital will be used to enhance the platform, expand reach, and continue innovating in youth behavioral healthcare. Leadership emphasized the company’s mission-driven focus and commitment to providing equitable, evidence-based digital support for young people. BeMe Health offers a digital-first, interventional behavioral health platform tailored specifically for teens, combining engaging content, mood reflection, skill-building activities, 1:1 coaching, connections to clinical services, and 24/7 crisis support. The platform was developed with input from an active Teen Advisory Board to ensure it aligns with teen needs and usage patterns. BeMe is delivered as a covered benefit through select health plans, employers, and community organizations and has seen growing adoption by health plans over the last year. The company says it is focusing on app enhancements for teens and expanding plan-level partnerships to broaden access. Recent recognitions for the company and its CEO include inclusion in Inc.’s Female Founders 200 and the Slice of Healthcare 50 Under 50, and a Signal Awards win for its podcast. The platform aims to meet teens where they are — on their phones — with a clinically validated, teen-centered approach. BeMe Health offers digital behavioral health services focused on teen mental health. The company’s approach centers on scaling digital interventions and support for adolescents. It raised $7 million in seed financing to accelerate and scale those operations. The funding will be deployed to expand BeMe’s offerings and operational capacity around its teen mental health approach. The founding team includes Scott Cousino and Ron Geraty; Cousino previously co-founded myStrength (acquired by Livongo) and Geraty has worked at Merit Behavioral Corp, American Imaging Management, and Alere. Two additional co-founders are Nicki Tessler (CEO) and Mandeep Dhillon (Chief Technical and Chief Product Officer).

Led · Seed · Oct 2022

Sonara (Sonara Health) offers a hybrid care platform combining in-person services and virtual tools—remote intake, telecounseling, in-app messaging, and real-time adherence insights—to improve initiation and retention in methadone treatment. The platform supports clinical decision-making around take-home dosing, dosage strength, accelerated induction, patient education, shared goal setting, and long-term recovery planning. Sonara positions its technology to remove barriers such as daily clinic travel while helping care teams stay connected between visits. Since launching in late 2022, the company has helped more than 1,000 patients across 50 clinics in 14 states. Led by CEO and founder Michael Giles, Sonara plans to use new funding to accelerate payer engagement and government relations to enable sustainable reimbursement for hybrid methadone models. It also intends to invest in technology-enabled medication units—both co-located and free-standing—to expand treatment access in high-need areas. Sonara Health provides a patented remote medication-monitoring system that enables patients to take methadone at home while eliminating daily clinic visits. The system combines a tamper-evident label with a patient-facing web application to guide daily consumption and a clinician-facing web application for remote, asynchronous observation. The company plans to use new funding to further develop its platform and to partner with more opioid treatment programs. Sonara conducted preliminary market research with OHSU and Stanford that associated use of its system with improved quality of life and early signs of better treatment retention. Sonara received a U.S. patent for its technology in September 2022. The company is led by CEO Michael Giles, M.D., and is based in Dallas, TX.

Participated · Seed · Aug 2021

MiResource operates an automated, online referral marketplace that guides patients and care providers to identify the right mental health care for individual needs. The platform creates hyperlocal micro-marketplaces via partnerships with university counseling centers and focuses primarily on university students. The company has established contracts with 25 university health systems and has helped connect over 50,000 students to a network of more than 5,000 mental health providers. Led by CEO Mackenzie Drazan and COO Gabriela Asturias, MiResource removes the knowledge burden from patients and providers to help them navigate the mental health care system. The company plans to use the new funding to continue expanding its automated referral platform. The article states the company is based in San Mateo, CA.

Participated · Equity · Sep 2018

InfoBionic develops the MoMe® ARC platform, a third-generation virtual telemetry system for remote, wireless monitoring and diagnosis of cardiac arrhythmias. Its MoMe® ARC 4-in-1 monitor pairs a 3rd-generation remote ECG device with a Bluetooth diagnostic 6-lead sensor and offers both patch-type and wire-based sensors. The system delivers heartbeat-to-heartbeat, full-disclosure ECG data over the cloud to provide near real-time, hospital telemetry-level access for clinicians. The company recently received FDA approval for the third-generation MoMe® ARC platform. InfoBionic plans to use the Series D proceeds to continue commercial expansion of the MoMe® ARC system. The company is led by CEO Stuart Long. InfoBionic develops the MoMe® Kardia remote cardiac monitoring platform that provides physicians 24/7 on-demand access to full-disclosure Holter, Event, and MCT data via a HIPAA-compliant portal. The system is positioned to replicate in-hospital telemetry data in the outpatient setting and was granted FDA 510(k) clearance in 2015. The company targets an addressable U.S. market estimated at $1.4 billion and recently announced a commercial distribution partnership to enhance market penetration. InfoBionic reports month-to-month subscription growth rates exceeding 35% since this time last year. The completed financing is intended to support continued commercial expansion of the MoMe® Kardia system. InfoBionic develops the MoMe® Kardia system, a cloud-based remote patient monitoring platform for cardiac arrhythmia detection. The platform streams continuous electrocardiogram, respiration and motion data to the cloud for analysis and delivers automated reporting to mobile devices, tablets and web portals. It provides on-demand, actionable monitoring data and analytics for Holter, Event and mobile cardiac telemetry (MCT) directly to physicians. The company is led by Nancy Briefs, President, CEO and Co-Founder. InfoBionic raised a financing round to support commercialization of the MoMe® Kardia system. The articles report the company is based in Lowell, Massachusetts. InfoBionic is an emerging digital health company focused on providing anywhere, anytime access to cardiac event monitoring with improved event detection and clinical efficacy through a lower-cost business model. Its lead product, the MoMe System, is a cloud-based, multi-pass analysis universal remote patient monitoring platform that provides seamless transition between Holter, Event, and Mobile Cardiac Telemetry monitoring modes in one device. MoMe Kardia is positioned to address the roughly $3B worldwide cardiac monitoring market by delivering enhanced analytics and on-demand access to patient data for diagnosis. Proceeds from the recently closed Series B tranche will enable commercialization of the MoMe System in Europe and the United States. The company emphasizes cloud technology to improve patient monitoring, diagnosis and treatment while reducing operating and healthcare costs. Safeguard Scientifics’ participation and board representation signal strategic support for commercialization and growth.

Led · Seed · May 2016

Healthify offers a SDoH referral platform and geo-targeted, intervention-focused networks that enable healthcare and social service organizations to track social needs, coordinate referrals, and measure intervention success within a single system. The company also works directly with social service organizations to develop and formalize contracts, ensuring accountability across its networks. Healthify supports constructed accountable networks of social service organizations that are geo-targeted to address community-specific needs. Led by CEO Manik Bhat and based in New York City, the company has worked with over 40 enterprise healthcare organizations and thousands of social service organizations. Financially, the company has raised over $28M to date through investments, grants, and awards, including a recent Series B. Healthify plans to use new funding to deepen relationships with current clients and drive growth in additional locales such as Kansas City, Phoenix, and Cincinnati. Healthify provides a platform that lets care teams search a database of more than 200,000 social services, screen patients for social needs, and coordinate electronic referrals with community-based organizations. The platform generates SDOH data that can be integrated into case management or electronic health record systems to support population health initiatives. Healthify works with managed care plans and healthcare providers in 30 states and helps more than 15,000 healthcare staff coordinate care for nearly five million Medicare Advantage and Medicaid beneficiaries. Led by co-founder and CEO Manik Bhat, the company will use new funding to expand its care coordination product suite and grow its network of customers and social service partners. To date the company has raised over $9.5M through investments, grants and awards. Healthify is a community health platform led by CEO Manik Bhat that helps managed care organizations and healthcare providers connect patients with community-based services to resolve unmet social needs. The platform enables healthcare staff to find and match appropriate community agencies for high-risk patients to improve overall health outcomes. Healthify already provides services in 24 states. The company intends to use new funding to refine its offerings and expand its coordination feature set into a nationwide network of insurers, healthcare providers, and community agencies. The article dates the news to May 17, 2016 and identifies the company as NYC-based. Healthify builds SaaS solutions to help care teams track, address, and engage with patients' social and behavioral health needs. Led by Co-Founder and CEO Manik Bhat, the company is a member of the Blueprint Health family. The platform is offered in both English and Spanish. Healthify already has deals with two large Medicaid managed care plans to help address the needs of some 20,000 patients in New York and Maryland. Following its launch in New York and Maryland, the company intends to use new funding to expand operations.